Cargando…
SAT-674 Anti PD1 Induced Type 1 Diabetes
Introduction: Pembrolizumab t is used to treat various cancers. It is associated with immune related adverse events (IRAEs) that can be life threatening [1,4]. We describe a patient who presented autoimmune Diabetes after the use of Pembrolizumab. Case: 64 y/o African American female PMHX of lung no...
Autores principales: | Naranjo, Maria Belen, Rosenthal, David S, Kumar, Salini Chellappan, Shariff, Amal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208844/ http://dx.doi.org/10.1210/jendso/bvaa046.412 |
Ejemplares similares
-
New Onset Autoimmune Diabetes Mellitus, Autoimmune Thyroiditis and Subsequent Autoimmune Hepatitis With Monoclonal Antibody to Programmed Cell Death-1 (PD-1) Protein Therapy in a Patient With Non Small Cell Lung Cancer: 18 Months Follow up Experience
por: Mandal, Kaushik, et al.
Publicado: (2021) -
MON-674 Diabetic Amyotrophy; A Rare Cause of Muscle Weakness
por: Abdallah, Duaa, et al.
Publicado: (2020) -
SAT-680 Diabetes Mellitus Induced by Programmed Cell Death-1 (PD-1) Inhibitors: A Case Report
por: Abuaisha, Munder, et al.
Publicado: (2020) -
SAT-677 A Case of Opdivo Induced Type 1 Diabetes
por: Lucier, Jessica, et al.
Publicado: (2020) -
SAT-176 Cellular Mechanisms of Impaired Bone Remodeling in Type 1 Diabetes Mellitus
por: Mehta, Shilpa, et al.
Publicado: (2019)